X-153695062-CCT-CCTCT
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_005629.4(SLC6A8):c.1768-8_1768-7dupTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000066 in 1,196,663 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000035 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000069 ( 0 hom. 24 hem. )
Consequence
SLC6A8
NM_005629.4 splice_region, intron
NM_005629.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.00700
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant X-153695062-C-CCT is Benign according to our data. Variant chrX-153695062-C-CCT is described in ClinVar as [Likely_benign]. Clinvar id is 1583949.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 24 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A8 | NM_005629.4 | c.1768-8_1768-7dupTC | splice_region_variant, intron_variant | ENST00000253122.10 | NP_005620.1 | |||
SLC6A8 | NM_001142805.2 | c.1738-8_1738-7dupTC | splice_region_variant, intron_variant | NP_001136277.1 | ||||
SLC6A8 | NM_001142806.1 | c.1423-8_1423-7dupTC | splice_region_variant, intron_variant | NP_001136278.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A8 | ENST00000253122.10 | c.1768-8_1768-7dupTC | splice_region_variant, intron_variant | 1 | NM_005629.4 | ENSP00000253122.5 | ||||
SLC6A8 | ENST00000430077.6 | c.1423-8_1423-7dupTC | splice_region_variant, intron_variant | 2 | ENSP00000403041.2 | |||||
SLC6A8 | ENST00000485324.1 | n.2075-8_2075-7dupTC | splice_region_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000355 AC: 4AN: 112688Hom.: 0 Cov.: 23 AF XY: 0.0000287 AC XY: 1AN XY: 34846
GnomAD3 genomes
AF:
AC:
4
AN:
112688
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34846
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000192 AC: 3AN: 156096Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 48106
GnomAD3 exomes
AF:
AC:
3
AN:
156096
Hom.:
AF XY:
AC XY:
0
AN XY:
48106
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000692 AC: 75AN: 1083975Hom.: 0 Cov.: 31 AF XY: 0.0000679 AC XY: 24AN XY: 353255
GnomAD4 exome
AF:
AC:
75
AN:
1083975
Hom.:
Cov.:
31
AF XY:
AC XY:
24
AN XY:
353255
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000355 AC: 4AN: 112688Hom.: 0 Cov.: 23 AF XY: 0.0000287 AC XY: 1AN XY: 34846
GnomAD4 genome
AF:
AC:
4
AN:
112688
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34846
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Creatine transporter deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at